|Year : 2015 | Volume
| Issue : 1 | Page : 1-4
Flavonoids as novel neuroprotective nutraceuticals
Department of Physiology, College of Medicine, University of Dammam, Dammam, Saudi Arabia
|Date of Web Publication||13-Feb-2015|
Department of Physiology, College of Medicine, University of Dammam, Dammam 31982
Source of Support: None, Conflict of Interest: None
Dementia/Neurodegenerative disorders result from chronic, progressive loss of neurons involved in cognition. Such disorders are characterized by more long-term care, chronic suffering and lost quality of life than any other disorder. Emerging evidence suggests that flavonoids may retard, block or even reverse such neurodegeneration. The purpose of this review is to assess effects, associations and mechanisms of action of flavonoids on neurons, to describe the recent advancements and to explore some current controversies surrounding the subject. PubMed, Google Scholar and university websites were searched. Additional studies were identified from reference lists.
Keywords: Cognition, dementia, flavonoids, learning, memory
|How to cite this article:|
Latif R. Flavonoids as novel neuroprotective nutraceuticals. Saudi J Health Sci 2015;4:1-4
| Introduction|| |
The potential impact of diet on health care costs should not be overlooked. According to the latest statistics by WHO worldwide nearly 35.6 million people suffer from dementia. This number is estimated to double by 2030 (65.7 million) and more than triple by 2050 (115.4 million). Treating and caring for people with dementia at present costs the world more than US$ 604 billion per year. This includes the health and social care cost and income loss of people with dementia and their caregivers. 
Gone are the days when cognitive decline and neurodegeneration was considered irreversible and a part of aging process. Modern research has revealed that the incidence and onset of these age-related neurodegenerative disorders can be significantly prevented or reversed by certain lifestyle modifications; diet being one of them. These findings provide favorable clues that the development of novel dietary approaches for improving cognitive health as we age is a real possibility.
This review will focus on the potential of flavonoids to influence memory, learning and cognitive performance and will attempt to elucidate the possible mechanisms that underpin such actions in the brain.
| Methods|| |
Literature search. A search of PubMed, Google Scholar and university websites was performed to identify original research/review articles/randomized controlled trials examining the effect of flavonoids on brain. Furthermore, we hand-searched bibliographic citations from the retrieved papers and from review articles. PubMed was searched using the term "flavonoids" (major subject heading) in combination with memory OR learning OR cognition OR dementia as free terms without any restrictions except language. Then, we screened the titles and abstracts resulting from the search strategies. Articles were rejected on initial screening if titles or abstracts were clearly irrelevant. The full text of potentially relevant articles was retrieved.
Flavonoids in the diet
Flavonoids are the most common group of polyphenolic compounds in the human diet. Major dietary sources of flavonoids include fruits, vegetables, cereals, dry legumes, tea, wine and chocolate.  The main dietary groups of flavonoids are (1) flavonols (found in onions and broccoli), (2) flavones (found in parsley and celery), (3) isoflavones (found in soy and soy products), (4) flavanones (found in citrus fruit and tomatoes), (5) flavanols (abundant in green tea, red wine, chocolate), and (6) anthocyanidins (in red wine and berry fruits).
After ingestion, flavonoids are metabolized extensively in the body, resulting in very different forms. ,
Bioavailability of flavonoids in the brain
Flavonoids can cross the blood-brain barrier as many of them have been found in the brain after oral administration. , The extent of their blood-brain barrier penetration depend on the lipophilicity of the compound  and its interaction with P Glycoprotein (a transporter expressed in blood-brain barrier). 
Cocoa and Cognition
Dietary intervention studies in a number of mammalian species, including man, using flavonoids have revealed that flavonoids may improve both memory and learning. ,,,, A prospective study of 10-year duration has provided a strong indication that regular dietary flavonoid intake is associated with a better neuro-cognitive performance with aging.  A total of 1640 subjects (aged ≥ 65 years) free from dementia at baseline and with reliable dietary assessment data were examined for their cognitive performance with a battery of test four times over a 10-year period. Flavonoid intake was positively associated with better cognitive performance at baseline and over time after adjustment for age, gender and education. Another cross-sectional study revealed that there was a dose-dependent, positive relationship between the intake of flavonoid-containing foods (chocolate, tea, wine) and cognitive performance.  A research involving 23 developed countries of the world has shown that dietary flavonoid consumption is linked with reduced incidence of dementia.  In accord with this observational data, several dietary intervention studies in both human subjects and animals, particularly those using flavonoid-rich tea, ,,,,, cocoa/chocolate ,, and blueberry ,,, have also confirmed positive effects on memory and learning.
The exact mechanisms by which flavonoids act in the brain remain unclear. Earlier, the biological actions of flavonoids on the brain were ascribed to their antioxidant potentials.  Later it was suggested that low concentration of flavonoids found in the brain  could not justify for their bioactivity in vivo over there. Instead, their neuroprotective potential depends on their ability to lessen neuronal vulnerability, enhance existing neuronal function and induce neurogenesis. ,
A growing number of flavonoid supplementation studies in animal models have provided significant information regarding their functions in brain. Emerging evidence suggests that flavanols improve the retention of rat spatial memory. The latent period to find a platform and the distance swum to a platform in a Morris water maze test are significantly reduced following flavonols supplementation in rats.  Reductions in the time taken to make a choice reveal enhanced memory, where rats have quick remembrance followed by a quick response. Investigations have pointed to many potential mechanisms as following:
Improved Cerebrovascular Functions
Cerebral blood flow is vital for optimal brain functions and it decreases with age and in disorders linked with dementia.  Brain imaging studies in human subjects have demonstrated that the consumption of flavanol-rich cocoa enhances cortical blood flow ,,, and induces angiogenesis and neurogenesis in the hippocampus.  There are several factors behind flavonoid-induced increased cerebral blood flow such as their potential to reduce BP,  improve endothelial functions,  and inhibit platelet aggregation  and inflammatory response. , Angiogenesis results from flavonoid-induced production of endothelial nitric oxide.  Neurogenesis results in response to the vascular growth factors.  Hippocampus is a brain region important for memory; therefore, flavonoids may influence memory by improved cortical blood flow, angiogenesis and neurogenesis in the region of hippocampus.
Alleviation of neuroinflammation and oxidative stress-induced injury
Neurotoxic and neuroinflammatory processes in the brain play a central role in the pathophysiology of Alzheimer's disease,  Parkinson's disease  and injury related with stroke.  Activated microglia and/or astrocytes release cytokines and other mediators that lead to the apoptotic death of neurons.
Flavonoids alleviate neuroinflammation by inhibiting (1) iNOS and cyclooxygenase 2 expression; (2) NO production; (3) cytokine release; (4) NADPH oxidase activation and subsequent reactive oxygen species generation in astrocytes and microglia. , These effects most likely depend on the flavonoids' potential of modulating protein kinase and lipid kinase signaling pathways. ,
Emerging evidence suggests that flavonoids may block oxidant-induced neuronal injury effectively.  However, the flavonoids' ability to do so does not depend on direct oxidant scavenging activity.  Rather, they act by modulating many protein kinase and lipid kinase signaling cascades, such as the PI3K/Akt, tyrosine kinase, protein kinase C and MAPK signaling pathways. 
Interaction with signaling cascade
Flavonoids induce both extracellular signal-regulated protein kinase (ERK) 1/2 and CREB activation in cortical neurons and subsequently increase CREB-regulated gene expression.  Owing to their ability to activate CREB, flavonoids may also regulate BDNF (Brain-derived neurotrophic factor), which has a role in synaptic plasticity and long-term memory  and is robustly induced in hippocampal neurons on synaptic stimulation.  BDNF belongs to the neurotrophin family of growth factors that play a pivotal role in learning and memory by forming new synaptic connections. It also affects the survival and function of neurons in the central nervous system.  Decreases in BDNF and pro-BDNF have been reported in Alzheimer's disease; , genetic  as well as pharmacological inhibition  of BDNF or its receptor tropomyosin receptor kinase B  impairs learning and memory. Conversely, agents that boost BDNF levels lead to enhanced spatial working memory. ,
Flavonoids have been reported to bind to mitochondrial ATPase.  They may also modulate mitochondrial transition pore, which controls cytochrome c release during apoptosis, , leading to subsequent inhibition of apoptosis.
It would be fair to say that current research does provide ample evidence for beneficial effects of flavonoids on neurons. Ongoing research using state-of-the-art recent technology, including functional MRI and transcranial Doppler ultrasound is offering further opportunities to reveal the mechanisms underpinning the effects of flavonoids on neurons. However, although flavonoid consumption may have the potential to forestall or even reverse age-dependent deteriorations in brain function, there are a number of questions still to be resolved. Above all, data in support of a causal relationship between the consumption of flavonoids and cognitive outcomes in human subjects is still lacking. Moreover, the exact chronological nature of flavonoid effects on memory is unclear till date, i.e., when shall we start consuming flavonoids to gain maximum beneficial effects? It is also unclear which flavonoids are most effective in inducing these changes.
In order to clarify and identify such relationships, future intervention studies will be required to utilize better characterized intervention materials, more appropriate controls and more rigorous clinical outcomes. Moreover, except few, , the majority of the studies investigating the impact of flavonoids on memory, learning and cognition involve the supplementation of whole foods and beverages, rich in a variety of different flavonoids. To establish a causal relationship between individual flavonoids and function, future studies investigating the effects of individual flavonoids shall be encouraged.
| Conclusion|| |
Development of a treatment that would forestall cognitive deterioration in older persons by only 1% per year would nullify all estimated increases in the long-term care costs for the aging population.  Also, there is keen interest in the development of drugs capable of enhancing memory and learning. There is a strong likelihood that in future, flavonoids, might act as precursors for a new class of memory-enhancing drugs.
| References|| |
Spencer JP, Abd El Mohsen MM, Minihane AM, Mathers JC. Biomarkers of the intake of dietary polyphenols: Strengths, limitations and application in nutrition research. Br J Nutr 2008;99:12-22.
Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: Chemistry, bioavailability and effects on health. Nat Prod Rep 2009;26:1001-43.
Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: Food sources and bioavailability. Am J Clin Nutr 2004;79:727-47.
Abd El Mohsen MM, Kuhnle G, Rechner AR, Schroeter H, Rose S, Jenner P, et al
. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 2002;33:1693-702.
Talavera S, Felgines C, Texier O, Besson C, Gil-Izquierdo A, Lamaison JL et al
. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J Agric Food Chem 2005;53:3902-8.
Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: In vitro
studies. J Neurochem 2003;85:180-92.
Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ
model of the blood-brain barrier. Free Radic Biol Med 2004;36:592-604.
Williams CM, El Mohsen MA, Vauzour D, Rendeiro C, Butler LT, Ellis JA, et al
. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med 2008;45:295-305.
Macready AL, Kennedy OB, Ellis JA, Williams CM, Spencer JP, Butler LT. Flavonoids and cognitive function: A review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr 2009;4:227-42.
Joseph JA, Shukitt-Hale B, Lau FC. Fruit polyphenols and their effects on neuronal signalling and behaviour in senescence. Ann N Y Acad Sci 2007;1100:470-85.
Shukitt-Hale B, Lau FC, Joseph JA. Berry fruit supplementation and the aging brain. J Agric Food Chem 2008;56:636-41.
Shukitt-Hale B, Carey A, Simon L, Mark DA, Joseph JA. Effects of Concord grape juice on cognitive and motor deficits in aging. Nutrition 2006;22:295-302.
Letenneur L, Proust-Lima C, Le Gouge A, Dartigues JF, Barberger- Gateau P. Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 2007;165:1364-71.
Nurk E, Refsum H, Drevon CA, Tell GS, Nygaard HA, Engedal K. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 2009;139:120-7.
Beking K, Vieira A. Flavonoid intake and disability-adjusted life years due to Alzheimer′s and related dementias: A population-based study involving twenty-three developed countries. Public Health Nutr 2010;13:1403-9.
Chan YC, Hosoda K, Tsai CJ, Yamamoto S, Wang MF. Favorable effects of tea on reducing the cognitive deficits and brain morphological changes in senescence-accelerated mice. J Nutr Sci Vitaminol (Tokyo) 2006;52:266-73.
Haque AM, Hashimoto M, Katakura M, Tanabe Y, Hara Y, Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 2006;136:1043-7.
Kaur T, Pathak CM, Pandhi P, Khanduja KL. Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats. Brain Cogn 2008;67:25-30.
Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S. Green tea consumption and cognitive function: A cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr 2006;83:355-61.
Lai HC, Chao WT, Chen YT, Yang VC. Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vitro
. Cancer Lett 2004;213: 181-8.
Unno K, Takabayashi F, Yoshida H, Choba D, Fukutomi R, Kikunaga N, et al
. Daily consumption of green tea catechin delays memory regression in aged mice. Biogerontology 2007;8:89-95.
Fisher ND, Sorond FA, Hollenberg NK. Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol 2006;47 Suppl 2:210-4.
Francis ST, Head K, Morris PG, Macdonald IA. The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 2006;47 Suppl 2:215-20.
Dinges DF. Cocoa flavanols, cerebral blood flow, cognition, and health: Going forward. J Cardiovasc Pharmacol 2006;47 Suppl 2:221-3.
Casadesus G, Shukitt-Hale B, Stellwagen HM, Zhu X, Lee HG, Smith MA, et al
. Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 2004;7:309-16.
Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, et al.
Blueberry supplementation improves memory in older adults. J Agric Food Chem 2010;58:3996-4000.
Rice-Evans CA, Miller NJ, Paganga G. Structure antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56.
Spencer JP. Flavonoids: Modulators of brain function? Br J Nutr 2008;99 Suppl 1:60-77.
Joseph JA, Shukitt-Hale B, Casadesus G. Reversing the deleterious effects of aging on neuronal communication and behavior: Beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr 2005;81:313-6S.
Spencer JP. Food for thought: The role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proc Nutr Soc 2008;67:238-52.
Rendeiro C, Spencer JP, Vauzour D, Butler LT, Ellis JA, Williams CM. The impact of flavonoids on spatial memory rodents: From behaviour to underlying hippocampal mechanisms. Genes Nutr 2009;4:251-70.
Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, et al
. Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam Study. Ann Neurol 2005;57:789-94.
Wang Z, Fernandez-Seara M, Alsop DC, Liu WC, Flax JF, Benasich AA, et al
. Assessment of functional development in normal infant brain using arterial spin labelled perfusion MRI. Neuroimage 2008;39:973-8.
Fraga CG, Litterio MC, Prince PD, Calabro V, Piotrkowski B, Galleano M. Cocoa flavanols: Effects on vascular nitric oxide and blood pressure. J Clin Biochem Nutr 2011;48:63-7.
Heiss C, Jahn S, Taylor M, Real WM, Angeli FS, Wong ML, et al
. Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. J Am Coll Cardiol 2010;56:218-24.
Murphy KJ, Chronopoulos AK, Singh I, Francis MA, Moriarty H, Pike MJ, et al
. Dietary flavanols and procyanidin oligomers fromcocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr 2003;77:1466-73.
Mao TK, van de Water J, Keen CL, Schmitz HH, Gershwin ME. Modulation of TNF-alpha secretion in peripheral blood mononuclear cells by cocoa flavanols and procyanidins. Dev Immunol 2002;9:135-41.
Mao TK, Van de Water J, Keen CL, Schmitz HH, Gershwin ME. Effect of cocoa flavanols and their related oligomers on the secretion of interleukin-5 in peripheral blood mononuclear cells. J Med Food 2002;5:17-22.
Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000;425:479-94.
McGeer EG, McGeer PL. Inflammatory processes in Alzheimer′s disease. Prog Neuropsycho pharmacol. Biol Psychiatry 2003;27:741-9.
Hirsch EC, Hunot S, Hartmann A. Neuroinflammatory processes in Parkinson′s disease. Parkinsonism Relat Disord 2005;11 Suppl 1:9-15.
Zheng Z, Lee JE, Yenari MA. Stroke: Molecular mechanisms and potential targets for treatment. Curr Mol Med 2003;3:361-72.
Lau FC, Bielinski DF, Joseph JA. Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. J Neurosci Res 2007;85:1010-7.
Li R, Huang YG, Fang D, Le WD. (-)-Epigallocatechingallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci Res 2004;78:723-31.
Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Radic Biol Med 2004;36:838-49.
Spencer JP. The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2007;2:257-73.
Vauzour D, Vafeiadou K, Corona G, Pollard SE, Tzounis X, Spencer JP. Champagne wine polyphenols protect primary cortical neurons against peroxynitrite-induced injury. J Agric Food Chem 2007;55:2854-60.
Spencer JP, Schroeter H, Kuhnle G, Srai SK, Tyrrell RM, Hahn U, et al
. Epicatechin and its in vivo
metabolite, 3′- O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochem J 2001;354:493-500.
Schroeter H, Bahia P, Spencer JP, Sheppard O, Rattray M, Rice-Evans C, et al
. (-)-Epicatechin stimulates ERK-dependent cyclic AMP response element activity and upregulates GLUR2 in cortical neurons. J Neurochem 2007;101:1596-606.
Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis. Prog Neurobiol 2005;76:99-125.
Patterson SL, Grover LM, Schwartzkroin PA, Bothwell M. Neurotrophin expression in rat hippocampal slices: A stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs. Neuron 1992;9:1081-8.
Thomas K, Davies A. Neurotrophins: A ticket to ride for BDNF. Curr Biol 2005;15:R262-4.
Peng S, Wuu J, Mufson EJ, Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer′s disease. J Neurochem 2005;93:1412-21.
Michalski B, Fahnestock M. Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer′s disease. Brain Res Mol Brain Res 2003;111:148-54.
Linnarsson S, Bjorklund A, Ernfors P. Learning deficit in BDNF mutant mice. Eur J Neurosci 1997;9:2581-7.
Mu JS, Li WP, Yao ZB, Zhou XF. Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Res 1999;835:259-65.
Minichiello L, Korte M, Wolfer D, Kuhn R, Unsicker K, Cestari V, et al
. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 1999;24:401-14.
Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006;124:471-84.
Matter WF, Brown RF, Vlahos CJ. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun 1992;186:624-31.
Di Pietro A, Godinot C, Bouillant ML, Gautheron DC. Pig heart mitochondrial ATPase: Properties of purified and membrane-bound enzyme. Effects of flavonoids. Biochimie 1975;57:959-67.
Medina JH, Viola H, Wolfman C, Marder M, Wasowski C, Calvo D et al
. Overview - flavonoids: A new family of benzodiazepine receptor ligands. Neurochem Res 1997;22:419-25.
Dekermendjian K, Kahnberg P, Witt MR, Sterner O, NielsenM, Liljefors T. Structure-activity relationships and molecular modelling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA (A) receptor complex. J Med Chem 1999;42:4343-50.
Van Praag H, Lucero MJ, Yeo GW, Stecker K, Heivand N, Zhao C, et al
. Plant-derived flavanol (-) epicatechin enhances angiogenesis and retention of spatial memory in mice. J Neurosci 2007;27:5869-78.
Jin CH, Shin EJ, Park JB, Jang CG, Li Z, Kim MS, et al
. Fustin flavonoid attenuates beta-amyloid (1-42)-induced learning impairment. J Neurosci Res 2009;87:3658-70.
Alzheimer′s Research UK (homepage on the internet). Dementia statistics [Updated 2013 July 5; Cited 2014 February 15]. Available from:www.alzheimers-research.org.uk/info/statistics/.
|This article has been cited by|
||Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders
| ||Rajib Paul,Joyobrato Nath,Satinath Paul,Muhammed Khairujjaman Mazumder,Banashree Chetiya Phukan,Rubina Roy,Pallab Bhattacharya,Anupom Borah |
| ||Neurochemistry International. 2021; : 105068 |
|[Pubmed] | [DOI]|
||Neuroprotective Properties of Common Lady’s Mantle Infusion
| ||I. V. Shilova,N. I. Suslov,I. A. Samylina,V. M. Baeva,N. B. Lazareva,E. V. Mazin |
| ||Pharmaceutical Chemistry Journal. 2020; |
|[Pubmed] | [DOI]|
||Flavonoid nutraceuticals and ionotropic receptors for the inhibitory neurotransmitter GABA
| ||Graham A.R. Johnston |
| ||Neurochemistry International. 2015; 89: 120 |
|[Pubmed] | [DOI]|